1. Home
  2. MXCT vs HOND Comparison

MXCT vs HOND Comparison

Compare MXCT & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • HOND
  • Stock Information
  • Founded
  • MXCT 1999
  • HOND 2024
  • Country
  • MXCT United States
  • HOND United States
  • Employees
  • MXCT N/A
  • HOND N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HOND
  • Sector
  • MXCT Health Care
  • HOND
  • Exchange
  • MXCT Nasdaq
  • HOND NYSE
  • Market Cap
  • MXCT 275.7M
  • HOND 292.1M
  • IPO Year
  • MXCT 2021
  • HOND 2024
  • Fundamental
  • Price
  • MXCT $2.21
  • HOND $10.90
  • Analyst Decision
  • MXCT Strong Buy
  • HOND
  • Analyst Count
  • MXCT 1
  • HOND 0
  • Target Price
  • MXCT $9.00
  • HOND N/A
  • AVG Volume (30 Days)
  • MXCT 811.6K
  • HOND 131.3K
  • Earning Date
  • MXCT 05-07-2025
  • HOND 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • HOND N/A
  • EPS Growth
  • MXCT N/A
  • HOND N/A
  • EPS
  • MXCT N/A
  • HOND 0.20
  • Revenue
  • MXCT $37,675,000.00
  • HOND N/A
  • Revenue This Year
  • MXCT $9.05
  • HOND N/A
  • Revenue Next Year
  • MXCT $19.98
  • HOND N/A
  • P/E Ratio
  • MXCT N/A
  • HOND $53.38
  • Revenue Growth
  • MXCT N/A
  • HOND N/A
  • 52 Week Low
  • MXCT $2.21
  • HOND $9.90
  • 52 Week High
  • MXCT $5.26
  • HOND $10.95
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 31.54
  • HOND N/A
  • Support Level
  • MXCT $2.60
  • HOND N/A
  • Resistance Level
  • MXCT $2.86
  • HOND N/A
  • Average True Range (ATR)
  • MXCT 0.15
  • HOND 0.00
  • MACD
  • MXCT -0.03
  • HOND 0.00
  • Stochastic Oscillator
  • MXCT 5.43
  • HOND 0.00

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About HOND HCM II ACQUISITION CORP

HCM II Acquisition Corp is a blank check company.

Share on Social Networks: